The majority of hepatocellular carcinoma occurs in patients with liver cirr
hosis. Although the tumors are often discovered at an early stage during su
rveillance of these patients, the underlying cirrhosis renders the surgery
more difficult and exposes the patients to higher rates of postoperative mo
rbidity and mortality than occurs in other types of liver surgery. Over the
past 20 years surgeons have developed new surgical procedures and techniqu
es to firstly reduce the unnecessary resection of liver parenchyma and to d
ecrease intraoperative blood loss. Better patient selection and understandi
ng of prognostic factors will hopefully result in a further decrease in ope
rative risk and postoperative recurrence. Adjuvant chemotherapy may prove e
ffective in reducing the postoperative recurrence but at this stage surgery
still remains as the best treatment for patients with recurrent tumor whic
h is accessible to resection.